N-Methyldeoxynojirimycin
CAS: 69567-10-8
Ref. 3D-MM04904
| 1mg | 156.00 € | ||
| 2mg | 195.00 € | ||
| 5mg | 325.00 € | ||
| 10mg | 506.00 € | ||
| 25mg | 1,013.00 € |
Product Information
- 1,5-Dideoxy-1,5-imino-1-methyl-D-sorbitolN-Me-DNJ
- (2R,3R,4R,5S)-2-(Hydroxymethyl)-1-methyl-3,4,5-piperidinetriol
- (2R,3R,4R,5S)-2-(hydroxymethyl)-1-methylpiperidine-3,4,5-triol
- 2-(Hydroxymethyl)-1-Methylpiperidine-3,4,5-Triol
- 3,4,5-Piperidinetriol, 2-(hydroxymethyl)-1-methyl-, (2R,3R,4R,5S)-
- 3,4,5-Piperidinetriol, 2-(hydroxymethyl)-1-methyl-, [2R-(2α,3β,4α,5β)]-
- Deoxynojirimycin, N-Methyl-
- Mor 14
- N-Methylmoranolin
- N-Methylmoranoline
- See more synonyms
N-Methyldeoxynojirimycin is a monoclonal antibody that is a competitive inhibitor of the melanoma antigen gp75. It is also an inhibitor of oligosaccharide synthesis and has been shown to have anti-inflammatory properties. N-Methyldeoxynojirimycin binds to the golgi alpha-mannosidases, preventing them from processing high-mannose type oligosaccharides. This leads to decreased chemoattractant protein production by neutrophils, which are important in the inflammatory process. N-Methyldeoxynojirimycin has also been shown to inhibit myocardial infarct size and glomerular filtration rate in rats, as well as increase biochemical markers for inflammation, such as α subunit of α1 acid glycoprotein and basic fibroblast growth factor.
Chemical properties
Technical inquiry about: 3D-MM04904 N-Methyldeoxynojirimycin
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
